Abstract
3H-Mepyramine labels specific histamine H1-receptors in brains of mice after intravenous injection. The potencies of H1-antihistamines in reducing 3H-mepyramine binding in vivo correspond to their pharmacological activities and show parallels with their affinities for 3H-mepyramine binding sites in isolated brain membranes. Several antidepressants are potent in competing for 3H-mepyramine binding in vivo as well as in vitro.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Antidepressive Agents / metabolism*
-
Binding Sites
-
Brain / metabolism
-
Chlorpheniramine / metabolism
-
Drug Interactions
-
Histamine Antagonists / metabolism*
-
In Vitro Techniques
-
Isotope Labeling*
-
Mice
-
Pyrilamine / metabolism
-
Receptors, Histamine / metabolism*
-
Receptors, Histamine H1 / metabolism*
-
Time Factors
-
Tritium
Substances
-
Antidepressive Agents
-
Histamine Antagonists
-
Receptors, Histamine
-
Receptors, Histamine H1
-
Tritium
-
Chlorpheniramine
-
Pyrilamine